Obesity paradox in chronic heart failure with moderately reduced or preserved left ventricular ejection fraction: impact on a prognosis for patients according to a five-year follow-up
DOI:
https://doi.org/10.14739/2310-1210.2023.4.280957Keywords:
chronic heart failure, moderately reduced ejection fraction, preserved ejection fraction, overweight, obesity, prognosisAbstract
Aim. To investigate the obesity paradox by studying the impact of overweight and abdominal obesity on the prognosis in chronic heart failure (CHF) patients with moderately reduced or preserved left ventricular ejection fraction (LVEF) by five-year follow-up results.
Materials and methods. A prospective, open, parallel-group study included 314 CHF patients with moderately reduced or preserved LVEF, average age was 65.3 ± 11.2 years. Group 1 – 66 patients with normal weight; Group 2 – 67 overweight patients; Group 3 – 90 patients with I degree abdominal obesity; Group 4 – 91 subjects with II–III degrees of obesity.
Adverse cardiovascular events (CVEs) were studied as a cumulative endpoint, cardiovascular death, and rehospitalization due to decompensated CHF.
Results. It has been found that excess body weight (overweight and I–III degrees of abdominal obesity) did not affect the prevalence and spectrum of adverse CVEs in CHF patients with moderately reduced and preserved LVEF. In overweight patients, compared to I degree obesity group, the incidence of cumulative end point (by 15.4 %; χ2 = 3.95, p < 0.05) and cases of re-hospitalization (by 19.0 %; χ2 = 5.6, p < 0.05) were more often observed.
Concomitant overweight was associated with an increased risk for faster onset of the cumulative end point (HR 1.46, 95 % CI 1.1–2.2, p < 0.05) and re-hospitalization (HR 1.53, 95 % CI 1.1–2.4, p < 0.05).
Conclusions. The presence of excess body weight (overweight and I–III degrees of abdominal obesity) did not affect the prevalence and spectrum of adverse CVEs in CHF patients with moderately reduced and preserved LVEF during the five-year follow-up. In the presence of overweight, in comparison with I degree abdominal obesity, the incidence of cumulative end point and re-hospitalization due to the disease decompensation were more often observed, which could be evidence for the existence of the obesity paradox.
The most adverse effect on the prognosis in CHF patients with moderately reduced and preserved LVEF caused by concomitant overweight, in the presence of which, there was a significant increase in the risk for more faster onset of cumulative end point and re-hospitalization due to decompensation of the disease.
References
Fröhlich, H., Frey, N., Frankenstein, L., & Täger, T. (2022). The Obesity Paradox in Heart Failure: Is It Still Valid in Light of New Therapies?. Cardiology, 147(5-6), 529-538. https://doi.org/10.1159/000527332
Elagizi, A., Carbone, S., Lavie, C. J., Mehra, M. R., & Ventura, H. O. (2020). Implications of obesity across the heart failure continuum. Progress in cardiovascular diseases, 63(5), 561-569. https://doi.org/10.1016/j.pcad.2020.09.005
Carbone, S., Canada, J. M., Billingsley, H. E., Siddiqui, M. S., Elagizi, A., & Lavie, C. J. (2019). Obesity paradox in cardiovascular disease: where do we stand?. Vascular health and risk management, 15, 89-100. https://doi.org/10.2147/VHRM.S168946
Zhang, J., Hayden, K., Jackson, R., & Schutte, R. (2020). Associations of weight changes with all-cause, cancer and cardiovascular mortality: A prospective cohort study. Public health in practice (Oxford, England), 2, 100065. https://doi.org/10.1016/j.puhip.2020.100065
Cunha, F. M., Pereira, J., Ribeiro, A., Silva, S., Araújo, J. P., Leite-Moreira, A., Bettencourt, P., & Lourenço, P. (2019). The cholesterol paradox may be attenuated in heart failure patients with diabetes. Minerva medica, 110(6), 507-514. https://doi.org/10.23736/S0026-4806.19.06067-1
Maurya, S. K., Carley, A. N., Maurya, C. K., & Lewandowski, E. D. (2023). Western Diet Causes Heart Failure With Reduced Ejection Fraction and Metabolic Shifts After Diastolic Dysfunction and Novel Cardiac Lipid Derangements. JACC. Basic to translational science, 8(4), 422-435. https://doi.org/10.1016/j.jacbts.2022.10.009
Zhao, L., Zhao, X., Tian, P., Liang, L., Huang, B., Huang, L., Feng, J., Zhang, Y., & Zhang, J. (2023). Predictive value of remnant cholesterol level for all-cause mortality in heart failure patients. Frontiers in cardiovascular medicine, 10, 1063562. https://doi.org/10.3389/fcvm.2023.1063562
González-Colaço Harmand, M., García-Sanz, M. D. M., Agustí, A., Prada-Arrondo, P. C., Domínguez-Rodríguez, A., Grandal-Leirós, B., Peña-Otero, D., Negrín-Mena, N., López-Hernández, J. J., & Díez-Villanueva, P. (2022). Review on the management of cardiovascular risk factors in the elderly. Journal of geriatric cardiology : JGC, 19(11), 894-927. https://doi.org/10.11909/j.issn.1671-5411.2022.11.008
Jin, J., Shi, Z., & Pang, X. (2021). Association between low-density lipoprotein cholesterol level and mortality in patients with cardiogenic shock: a retrospective cohort study. BMJ open, 11(7), e044668. https://doi.org/10.1136/bmjopen-2020-044668
Ozcan Cetin, E. H., Cetin, M. S., Özbay, M. B., Yaman, N. M., Könte, H. C., Ekizler, F. A., Tak, B. T., Kara, M., Temizhan, A., Özcan, F., Özeke, Ö., Çay, S., Topaloglu, S., & Aras, D. (2020). The other side of the medallion in heart failure: Reverse metabolic syndrome. Nutrition, metabolism, and cardiovascular diseases : NMCD, 30(11), 2041-2050. https://doi.org/10.1016/j.numecd.2020.06.027
Huang, Z. M., Chen, W. R., Su, Q. W., & Huang, Z. W. (2021). Prognostic Impact of Metabolic Syndrome in Patients With Heart Failure: A Meta-Analysis of Observational Studies. Frontiers in cardiovascular medicine, 8, 704446. https://doi.org/10.3389/fcvm.2021.704446
Prausmüller, S., Heitzinger, G., Pavo, N., Spinka, G., Goliasch, G., Arfsten, H., Gabler, C., Strunk, G., Hengstenberg, C., Hülsmann, M., & Bartko, P. E. (2022). Malnutrition outweighs the effect of the obesity paradox. Journal of cachexia, sarcopenia and muscle, 13(3), 1477-1486. https://doi.org/10.1002/jcsm.12980
Liu, L., Qian, J., Li, Y., Ni, Y., Zhao, Y., & Che, L. (2023). Effects of obesity on short-term mortality in patients with acute heart failure under different nutritional status. BMC cardiovascular disorders, 23(1), 221. https://doi.org/10.1186/s12872-023-03206-x.
Chien, S. C., Chandramouli, C., Lo, C. I., Lin, C. F., Sung, K. T., Huang, W. H., Lai, Y. H., Yun, C. H., Su, C. H., Yeh, H. I., Hung, T. C., Hung, C. L., & Lam, C. S. P. (2021). Associations of obesity and malnutrition with cardiac remodeling and cardiovascular outcomes in Asian adults: A cohort study. PLoS medicine, 18(6), e1003661. https://doi.org/10.1371/journal.pmed.1003661
McGranaghan, P., Saxena, A., Düngen, H. D., Rubens, M., Appunni, S., Salami, J., Veledar, E., Lacour, P., Blaschke, F., Obradovic, D., Loncar, G., Tahirovic, E., Edelmann, F., Pieske, B., & Trippel, T. D. (2021). Performance of a cardiac lipid panel compared to four prognostic scores in chronic heart failure. Scientific reports, 11(1), 8164. https://doi.org/10.1038/s41598-021-87776-w
Aoki, S., Yamagishi, K., Kihara, T., Tanaka, M., Imano, H., Muraki, I., Shimizu, Y., Hayama-Terada, M., Umesawa, M., Sankai, T., Okada, T., Kitamura, A., Kiyama, M., & Iso, H. (2023). Risk factors for pre-heart failure or symptomatic heart failure based on NT-proBNP. ESC heart failure, 10(1), 90-99. https://doi.org/10.1002/ehf2.14149
Butt, J. H., Petrie, M. C., Jhund, P. S., Sattar, N., Desai, A. S., Køber, L., Rouleau, J. L., Swedberg, K., Zile, M. R., Solomon, S. D., Packer, M., & McMurray, J. J. V. (2023). Anthropometric measures and adverse outcomes in heart failure with reduced ejection fraction: revisiting the obesity paradox. European heart journal, 44(13), 1136-1153. https://doi.org/10.1093/eurheartj/ehad083
Fu, L., Zhou, Y., Sun, J., Zhu, Z., & Tai, S. (2022). Abdominal Obesity Is Associated with an Increased Risk of All-Cause Mortality in Males but Not in Females with HFpEF. Cardiovascular therapeutics, 2022, 2950055. https://doi.org/10.1155/2022/2950055
Fonseca, G. W. P. D., & von Haehling, S. (2022). The fatter, the better in old age: the current understanding of a difficult relationship. Current opinion in clinical nutrition and metabolic care, 25(1), 1-6. https://doi.org/10.1097/MCO.0000000000000802
Guo, L., Liu, X., Yu, P., & Zhu, W. (2022). The "Obesity Paradox" in Patients With HFpEF With or Without Comorbid Atrial Fibrillation. Frontiers in cardiovascular medicine, 8, 743327. https://doi.org/10.3389/fcvm.2021.743327
Fushtey, I. M., Podsevakhina, S. L., Palamarchuk, A. I., & Tkachenko, O. V. (2021). Features of dyslipidemia and its influence on endothelium functional state in patients with rheumatoid arthritis and arterial hypertension. Modern Medical Technology, (1), 4-9. https://doi.org/10.34287/MMT.1(48).2021.1
Sciomer, S., Moscucci, F., Salvioni, E., Marchese, G., Bussotti, M., Corrà, U., & Piepoli, M. F. (2020). Role of gender, age and BMI in prognosis of heart failure. European journal of preventive cardiology, 27(2_suppl), 46-51. https://doi.org/10.1177/2047487320961980
Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J., Coats, A., Falk, V., González-Juanatey, J. R., Harjola, V. P., Jankowska, E. A., Jessup, M., Linde, C., Nihoyannopoulos, P., Parissis, J. T., Pieske, B., Riley, J. P., Rosano, G., Ruilope, L. M., Ruschitzka, F., Rutten, F. H., … ESC Scientific Document Group (2016). 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. European heart journal, 37(27), 2129-2200. https://doi.org/10.1093/eurheartj/ehw128
Voronkov, L. H., Amosova, K. M., Dziak, H. V., Zharinov, O. Y., Kovalenko, V. M., Korkushko, O. V., Nesukai, O. H., Sychov, O. S., Rudyk, Yu. S., & Parkhomenko, O. M. (2017). Rekomendatsii Asotsiatsii kardiolohiv Ukrainy z diahnostyky ta likuvannia khronichnoi sertsevoi nedostatnosti (2017) [Guidelines of the Ukrainian Association of Cardiology for the Diagnosis and Treatment of Chronic Heart Failure (2017)]. Sertseva nedostatnist ta komorbidni stany, (1_suppl 1), 1-66. [in Ukrainian].
Cunha, F. M., Pereira, J., Ribeiro, A., Silva, S., Araújo, J. P., Leite-Moreira, A., Bettencourt, P., & Lourenço, P. (2019). The cholesterol paradox may be attenuated in heart failure patients with diabetes. Minerva medica, 110(6), 507-514. https://doi.org/10.23736/S0026-4806.19.06067-1
Downloads
Published
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)
